ORLANDO, Fla., April 24 /PRNewswire-FirstCall/ -- Telzuit Medical Technologies, Inc. announced today the availability of an informational research report on the Company issued by Harbinger Research, LLC. The report details Telzuit's business model, product pipeline and the competitive advantages of the Company's forthcoming Bio-Patch Wireless Holter Monitor System. The full research report can be accessed at the following link:
Please copy & paste the below URL into your web browser. http://www.harbingerresearch.com/data/TZMT%20Telzuit%20Medical%20Technologies% 20Harbinger%20Investment%20Report%20%2004.20.06.pdf
About Telzuit Medical Technologies, Inc.
Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine for people worldwide. The company is in the final stages of launching its first product, the FDA-approved Bio-Patch Wireless Heart Monitor. The Bio-Patch is a full 12-lead, completely wireless Holter monitor, which is new to the marketplace. In conjunction with its strategic partners, Telzuit is also building its own dedicated intranet platform to handle several of the products it will be releasing, including the Bio-Patch. Telzuit is based in Orlando, Florida. For more information Telzuit, its business model and its products, please visit the company's website: http://www.telzuit.com .
Contact: Telzuit Medical Technologies, Inc. James Tolan Co-Founder, Telzuit Medical Technologies, Inc. 407-354-1222 Brainerd Communicators, Inc. Jennifer Gery (media) Todd St.Onge (investors) 212-986-6667
Telzuit Medical Technologies, Inc.CONTACT: James Tolan, Co-Founder of Telzuit Medical Technologies, Inc.,+1-407-354-1222; or for media: Jennifer Gery, or for investors: ToddSt.Onge, both of Brainerd Communicators, Inc. for Telzuit MedicalTechnologies, Inc., +1-212-986-6667
Web site: http://www.telzuit.com/